Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Wet Age-related Macular Degeneration”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT06398080
What this trial is testing

An Observational Study to Investigate the Use of Aflibercept 8 mg to Treat Adult Patients With Neovascular Age-Related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME) in a Real-World Setting

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)Wet Age-related Macular Degeneration (AMD)Diabetic Macular Edema (DME)+1 more
Regeneron Pharmaceuticals
Post-approval studies (Phase 4)WithdrawnNCT04698850
What this trial is testing

Brolucizumab vs. Aflibercept for Retinal Angiomatous Proliferation

Who this might be right for
Wet Macular Degeneration
Faculty Hospital Kralovske Vinohrady
Large-scale testing (Phase 3)Study completedNCT05439629
What this trial is testing

Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Macular Degeneration

Who this might be right for
Neovascular (Wet) Age-related Macular Degeneration
Bio-Thera Solutions 488
Large-scale testing (Phase 3)Study completedNCT04480463
What this trial is testing

Comparing SCD411 and Eylea® in Subjects With Wet Age-related Macular Degeneration (AMD)

Who this might be right for
Wet Age-related Macular DegenerationNeovascular Age-related Macular Degeneration
Sam Chun Dang Pharm. Co. Ltd. 576
Not applicableStudy completedNCT03382587
What this trial is testing

Observational Study to Assess Intravitreal Aflibercept Injections Used in a "Treat and Extend" Regimen in Treatment-naïve Wet Age-related Macular Degeneration Patients

Who this might be right for
Wet Age-related Macular Degeneration
Bayer 163
Testing effectiveness (Phase 2)Study completedNCT01678963
What this trial is testing

Efficacy and Safety of Squalamine Lactate Eye Drops in Subjects With Neovascular (Wet) Age-related Macular Degeneration (AMD)

Who this might be right for
Neovascular Age Related Macular Degeneration
Ohr Pharmaceutical Inc. 142
Early research (Phase 1)Study completedNCT01997164
What this trial is testing

Study of Intravitreal (IVT) REGN910-3 and IVT REGN910 in Patients With Either Neovascular ("Wet") Age Related Macular Degeneration (AMD) or Diabetic Macular Edema (DME)

Who this might be right for
Neovascular Age-Related Macular DegenerationDiabetic Macular Edema
Regeneron Pharmaceuticals 20
Not applicableStudy completedNCT01363570
What this trial is testing

Evaluation of Wet Age-Related Macular Degeneration (AMD) Genetic Profile Interactions With Ranibizumab Treatment Outcomes

Who this might be right for
Age Related Macular Degeneration
McMaster University 70
Large-scale testing (Phase 3)WithdrawnNCT02036723
What this trial is testing

Safety and Efficacy Study of BCD-021 Compared to Lucentis® in Patients With Neovascular Wet Age-related Macular Degeneration

Who this might be right for
Wet Age-related Macular Degeneration
Biocad
Not applicableStudy completedNCT04685369
What this trial is testing

Effectiveness of Anti-VEGF Treatments in Wet AMD in Active Smokers

Who this might be right for
Wet Age-related Macular Degeneration
Brugmann University Hospital 148
Large-scale testing (Phase 3)Study completedNCT05003245
What this trial is testing

Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD

Who this might be right for
Age Related Macular Degeneration
Shanghai Henlius Biotech 407
Testing effectiveness (Phase 2)Study completedNCT01016873
What this trial is testing

INTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMD

Who this might be right for
AMDWet AMDAge-Related Macular Degeneration+4 more
Oraya Therapeutics, Inc. 230
Not applicableNot Yet RecruitingNCT05780931
What this trial is testing

Rehabilitating Vision Loss in Veterans With Age-Related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration (AMD)
VA Office of Research and Development 20
Not applicableStudy completedNCT04137120
What this trial is testing

Study to Gather Information on the Safety and Use of Aflibercept Injections Into the Eye for the Treatment of Eye Disorders in Mexican Routine Clinical Practice

Who this might be right for
Retinal Disease
Bayer 73
Testing effectiveness (Phase 2)Study completedNCT00239928
What this trial is testing

Clinical Study Of Pegaptanib Sodium (EYE001) For Wet-Type Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
Pfizer 61
Large-scale testing (Phase 3)Study completedNCT01748292
What this trial is testing

Treat & Extend Treatment With 0.5mg Ranibizumab vs Monthly Treatment With 0.5mg Ranibizumab

Who this might be right for
Macular Degeneration
Charles C Wykoff, PhD, MD 60
Not applicableLooking for participantsNCT02253030
What this trial is testing

OCT Angiography in Wet AMD

Who this might be right for
Neovascular (Wet) Age-related Macular Degeneration (AMD)
Oregon Health and Science University 160
Not applicableStudy completedNCT02287298
What this trial is testing

Triple Combination Therapy of Choroidal Neovascularization in AMD, a Cost Effect and Efficient Therapeutic Treatment

Who this might be right for
Exudative Macular Degeneration
The Retina Center of St. Louis County, PC 400
Early research (Phase 1)Study completedNCT04635800
What this trial is testing

Evaluate the Safety, Tolerability and Pharmacokinetics of IVT MHU650 in Macular Edema Patients

Who this might be right for
Macular EdemaDiabetic Macular EdemaNeovascular Age-related Macular Degeneration+1 more
Novartis Pharmaceuticals 21
Not applicableUnknownNCT01920867
What this trial is testing

Stem Cell Ophthalmology Treatment Study

Who this might be right for
Retinal DiseaseMacular DegenerationHereditary Retinal Dystrophy+2 more
MD Stem Cells 300
Next Page